We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

August 14, 2018

Status of AI and Machine Learning in Radiology

Commentary
Tom Parsons
&

News and hype surround the field of radiology with headlines around the world purporting that it will be disrupted overnight. Few companies though really have the evidence to back up these claims.

A combination of factors have led to this field being a target for innovators including the expansion of image archiving, the increase of diagnostic image-sharing and the computer-readable DICOM format.

These innovative companies are seeking to apply AI, Machine and Deep Learning to this field in the hope of achieving time and cost savings, and to help doctors detect changes such as tumors, hardening of the arteries and provide highly accurate measurements of organs and blood flow.

Even though in principal the challenges in this field are ripe for the application of modern technology, there are considerable market barriers new companies must face. These barriers include regulatory challenges, how the technology is integrated into the clinical workflow and the learning curve for those clinicians who must be trained to use the tool.

These barriers have not held some innovative companies back, below we highlight some of the best of these technologies as well as hear from experts in the field on what to expect in the future.

Selection of Recent Regulatory Winners

Arterys, is developing imaging analytics software solutions deployed via their cloud-based medical imaging deep learning platform. Arterys recently received FDA Clearance for a broad Oncology Imaging Suite which covers all solid tumors, its fifth 510(k) clearance from the FDA. The first deep learning workflows will be for lung CT scans, and liver MRI and CT scans. Using this solution, radiologists can easily confirm, evaluate, quantify, and report on the absence or presence of lung nodules and liver lesions along with their key characteristics using a simple web browser. GE Ventures is an investor.

“The potential of AI is not only to improve clinical insights and productivity for both the radiologist and the provider facility, but it also extends to expanding geographic access to advanced diagnostic capabilities and service lines so that more patients can benefit. The market is early in the adoption of these solutions, and their full impact is only beginning to be understood and appreciated.” - Leslie Bottorff, Managing Director, GE Ventures

“The potential of AI is not only to improve clinical insights and productivity for both the radiologist and the provider facility, but it also extends to expanding geographic access to advanced diagnostic capabilities and service lines so that more patients can benefit. The market is early in the adoption of these solutions, and their full impact is only beginning to be understood and appreciated.”

Zebra Medical Vision is developing algorithms to assist radiologists in detecting often overlooked indications in CT scans. Their algorithms can be applied to detect low bone mineral density, breast cancer, fatty liver, coronary artery calcium, emphysema with a flat rate of $1 per scan analysed in their cloud. This week Zebra announced the CE regulatory approval of its newest algorithm to be included in its growing Deep Learning Imaging Analytics platform. The algorithm, capable of detecting Intracranial Hemorrhages is the latest addition to their “All-In-One” AI1 business model.

It’s All About Workflow

Getting an algorithm certified is just the first step. It then has to be integrated into the providers existing systems. Ideally, AI will run automatically, producing discrete assessments that the radiologist can validate. Once approved, the data can be pulled into the EHR, where downstream providers can act accordingly. Several of the imaging analytics start-ups including Arterys and Zebra have developed cloud-based platforms for integration into the existing workflow. However, even with cloud infrastructure, there may be challenges associated with integrating these AI platforms with providors systems.

"When grasping the whole spectrum of radiomics tools and applications, it will be challenging to seamlessly integrate into radiology workflow" - Faiq Shaikh M.D, Director Life Sciences Research,Clusterone, Inc.

“Its an incredibly exciting time for AI applications, particularly in imaging…..However, I think what people need to understand is that there are already very large numbers of algorithms that are out there and have been developed over the last 20-30 years or so. What we really need is a better delivery mechanism to be able to create a platform so that they can be disseminated and actually available and implemented in daily practice. What one really needs is the ability to index those files, navigate databases, to be able to task and develop those algorithms for a particular area” Eliot Siegel M.D, Professor of Diagnostic Radiology and Nuclear Medicine, University of Maryland

Clinician Engagement is Key

Initially media on AI in radiology has conjured up fear of computers replacing radiologists. The focus now, is less on how to avoid it, and more on how radiologists can leverage it successfully.

“Most projects and startups focus on big data in imaging analytics which is the obvious perspective. I think, however, an even more interesting perspective is a patient's serial data especially in cardiology with echocardiograms. What the clinicians need is an analytical methodology in which any changes in echocardiogram month to month/ year to year can be easily delineated. Rarely is this being addressed and this is yet another example of a lack of clinician-data scientist synergy." - Anthony C. Chang M.D, Chief Intelligence and Innovation Officer, Children’s Hospital of Orange County

Companies have made great progress with bringing AI imaging analytics solutions to market, however in many cases it remains to be seen if these solutions will perform as expected in real-world settings. Delivery and infrastructure mechanisms need to be optimized as they are critical for clinical adoption and success in this space.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: DTx Reimbursement in the US - PBMs as Coverage Scale Catalysts

10th August @ 10:45AM EDT

Are you a DTx or Pharma company seeking wide-spread reimbursement of a DTx product in the US? Join this Masterclass led by Mike Pace to learn more about this topic and share your experiences with others working in this space.

Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Value, Cost and Pricing in Regulated Digital Health Solutions

11th August @ 10:45AM EDT

Digital Health solutions are top of mind for biopharma companies in 2022, and Software as Medical Device (SaMD) is a crucial cornerstone for top-tier companies. Join this Masterclass led by BrightInsight to dive deeper into this topic and discuss this further with your peers working in this space.

Featuring
David Matthews, PhD
David Matthews, PhD
CCO, BrightInsight
Featuring
David Matthews, PhD
David Matthews, PhD
CCO, BrightInsight
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sustainable Business Models for DTx

16th August @ 10:45AM EDT

It is one of the key questions that every digital therapeutic (DTx) company must answer - what business model will set them up for success in the long run? Join this meeting to discuss this further and share your experiences with your peers working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Payers Partnerships for DTx

17th August @ 10:45AM EDT

Digital Therapeutics (DTx) vendors face many challenges on their journey to commercialization, such as generating clinical data, health economics evidence and achieving regulatory status. Join this meeting to discuss this topic further and share your experiences with others working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Kevin Darcy
Kevin Darcy
Director, Link Strategy at Veeva Systems
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Kevin Darcy
Kevin Darcy
Director, Link Strategy at Veeva Systems

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: DTx Reimbursement in the US - PBMs as Coverage Scale Catalysts

10th August @ 10:45AM EDT

Are you a DTx or Pharma company seeking wide-spread reimbursement of a DTx product in the US? Join this Masterclass led by Mike Pace to learn more about this topic and share your experiences with others working in this space.

Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Value, Cost and Pricing in Regulated Digital Health Solutions

11th August @ 10:45AM EDT

Digital Health solutions are top of mind for biopharma companies in 2022, and Software as Medical Device (SaMD) is a crucial cornerstone for top-tier companies. Join this Masterclass led by BrightInsight to dive deeper into this topic and discuss this further with your peers working in this space.

Featuring
David Matthews, PhD
David Matthews, PhD
CCO, BrightInsight
Featuring
David Matthews, PhD
David Matthews, PhD
CCO, BrightInsight

Executive 1-2-1 with the HealthXL Digital Health Community

15th August @11AM EDT

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Featuring
Aahuti Rai
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Chris Wasden
Chris Wasden
Head of Pharma Speciality Solutions & Corporate Strategy, Twill
Featuring
Aahuti Rai
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Chris Wasden
Chris Wasden
Head of Pharma Speciality Solutions & Corporate Strategy, Twill
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sustainable Business Models for DTx

16th August @ 10:45AM EDT

It is one of the key questions that every digital therapeutic (DTx) company must answer - what business model will set them up for success in the long run? Join this meeting to discuss this further and share your experiences with your peers working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.